Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
Authors: Abdallah MS; Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt., Mosalam EM; Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebeen El-Kom, Egypt., Hassan A; Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt., Ramadan AN; Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt., Omara-Reda H; Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt., Zidan AA; Zoology Department, Faculty of Science, Damanhour University, Damanhour, Egypt., Samman WA; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Saudi Arabia., El-Berri EI; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Jan; Vol. 29 (1), pp. 354-364. Date of Electronic Publication: 2022 Nov 07.
Publication Type: Randomized Controlled Trial; Journal Article; Retracted Publication
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-5949 (Electronic) Linking ISSN: 17555930 NLM ISO Abbreviation: CNS Neurosci Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1755-5949
DOI:10.1111/cns.14010